BBC3 and colorectal cancer: Song et al. found that regorafenib treatment resulted in strong binding of MCL-1 to PUMA and that inhibition of MCL-1 with S63845 freed PUMA to facilitate regorafenib-induce apoptosis in MCL-1 knock-in colorectal cancer cells [83, 84].